CoChat
Sign Up
Cited by 108

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition

Inoue, Daichi, Polaski, Jacob T., Taylor, Justin, Castel, Pau, Chen, Sisi, Kobayashi, Susumu, Hogg, Simon J., Hayashi, Yasutaka, Pineda, Jose Mario Bello, El Marabti, Ettaib, Erickson, Caroline, Knorr, Katherine, Fukumoto, Miki, Yamazaki, Hiromi, Tanaka, Atsushi, Fukui, Chie, Lu, Sydney X., Durham, Benjamin H., Liu, Bo, Wang, Eric, Mehta, Sanjoy, Zakheim, Daniel, Garippa, Ralph, Penson, Alex, Chew, Guo-Liang, McCormick, Frank, Bradley, Robert K., Abdel-Wahab, Omar·2021·Nature Genetics
DOI 10.1038/s41588-021-00828-9PMC PMC8177065
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41588-021-00828-9

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 54

  1. Papaemmanuil, E. et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122, 3616–3627 (2013). · DOI · Paper page
  2. Ilagan, J. O. et al. U2AF1 mutations alter splice site recognition in hematological malignancies. Genome Res. 25, 14–26 (2014). · DOI
  3. Darman, R. B. et al. Cancer-associated SF3B1 hotspot mutations induce cryptic 3′ splice site selection through use of a different branch point. Cell Rep. 13, 1033–1045 (2015). · DOI
  4. Madan, V. et al. Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome. Nat. Commun. 6, 6042 (2015). · DOI
  5. Gault, C. M. et al. Aberrant splicing in maize rough endosperm3 reveals a conserved role for U12 splicing in eukaryotic multicellular development. Proc. Natl Acad. Sci. USA 114, E2195–E2204 (2017). · DOI
  6. Tarn, W. Y. & Steitz, J. A. A novel spliceosome containing U11, U12, and U5 snRNPs excises a minor class (AT–AC) intron in vitro. Cell 84, 801–811 (1996). · DOI
  7. Hall, S. L. & Padgett, R. A. Conserved sequences in a class of rare eukaryotic nuclear introns with non-consensus splice sites. J. Mol. Biol. 239, 357–365 (1994). · DOI
  8. Tarn, W. Y. & Steitz, J. A. Highly diverged U4 and U6 small nuclear RNAs required for splicing rare AT–AC introns. Science 273, 1824–1832 (1996). · DOI
  9. Hall, S. L. & Padgett, R. A. Requirement of U12 snRNA for in vivo splicing of a minor class of eukaryotic nuclear pre-mRNA introns. Science 271, 1716–1718 (1996). · DOI
  10. Burge, C. B., Padgett, R. A. & Sharp, P. A. Evolutionary fates and origins of U12-type introns. Mol. Cell 2, 773–785 (1998). · DOI
  11. Patel, A. A., McCarthy, M. & Steitz, J. A. The splicing of U12-type introns can be a rate-limiting step in gene expression. EMBO J. 21, 3804–3815 (2002). · DOI
  12. Younis, I. et al. Minor introns are embedded molecular switches regulated by highly unstable U6atac snRNA. eLife 2, e00780 (2013). · DOI
  13. Challen, G. A. et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat. Genet. 44, 23–31 (2011). · DOI · Paper page
  14. Li, Q. et al. Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus. Blood 117, 2022–2032 (2011). · DOI
  15. Markmiller, S. et al. Minor class splicing shapes the zebrafish transcriptome during development. Proc. Natl Acad. Sci. USA 111, 3062–3067 (2014). · DOI
  16. Doggett, K. et al. Early developmental arrest and impaired gastrointestinal homeostasis in U12-dependent splicing-defective Rnpc3-deficient mice. RNA 24, 1856–1870 (2018). · DOI
  17. Otake, L. R., Scamborova, P., Hashimoto, C. & Steitz, J. A. The divergent U12-type spliceosome is required for pre-mRNA splicing and is essential for development in Drosophila. Mol. Cell 9, 439–446 (2002). · DOI
  18. Baumgartner, M. et al. Minor spliceosome inactivation causes microcephaly, owing to cell cycle defects and death of self-amplifying radial glial cells. Development 145, dev166322 (2018). · DOI
  19. Lee, S. C. et al. Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations. Cancer Cell 34, 225–241 (2018). · DOI · Paper page
  20. Taylor, J. et al. Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Blood 136, 1477–1486 (2020). · DOI
  21. Tyner, J. W. et al. Functional genomic landscape of acute myeloid leukaemia. Nature 562, 526–531 (2018). · DOI · Paper page
  22. Van Nostrand, E. L. et al. Robust, cost-effective profiling of RNA binding protein targets with single-end enhanced crosslinking and immunoprecipitation (seCLIP). Methods Mol. Biol. 1648, 177–200 (2017). · DOI
  23. Pineda, J. M. B. & Bradley, R. K. Most human introns are recognized via multiple and tissue-specific branchpoints. Genes Dev. 32, 577–591 (2018). · DOI
  24. Inoue, D. et al. Spliceosomal disruption of the non-canonical BAF complex in cancer. Nature 574, 432–436 (2019). · DOI
  25. Bigenzahn, J. W. et al. LZTR1 is a regulator of RAS ubiquitination and signaling. Science 362, 1171–1177 (2018). · DOI
  26. Castel, P. et al. RIT1 oncoproteins escape LZTR1-mediated proteolysis. Science 363, 1226–1230 (2019). · DOI
  27. Steklov, M. et al. Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination. Science 362, 1177–1182 (2018). · DOI
  28. Frattini, V. et al. The integrated landscape of driver genomic alterations in glioblastoma. Nat. Genet. 45, 1141–1149 (2013). · DOI · Paper page
  29. Piotrowski, A. et al. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat. Genet. 46, 182–187 (2014). · DOI
  30. Johnston, J. J. et al. Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants. Genet. Med. 20, 1175–1185 (2018). · DOI
  31. Berger, A. H. et al. Oncogenic RIT1 mutations in lung adenocarcinoma. Oncogene 33, 4418–4423 (2014). · DOI
  32. Aoki, Y. et al. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. Am. J. Hum. Genet. 93, 173–180 (2013). · DOI
  33. Pollard, K. S., Hubisz, M. J., Rosenbloom, K. R. & Siepel, A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 20, 110–121 (2010). · DOI · Paper page
  34. Rosenbloom, K. R. et al. The UCSC Genome Browser database: 2015 update. Nucleic Acids Res. 43, D670–D681 (2015). · DOI
  35. Pellagatti, A. et al. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations. Blood 132, 1225–1240 (2018). · DOI
  36. Cheng, D. T. et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J. Mol. Diagn. 17, 251–264 (2015). · DOI · Paper page
  37. Gothert, J. R. et al. In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis. Blood 105, 2724–2732 (2005). · DOI · Paper page
  38. Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014). · DOI · Paper page
  39. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010). · DOI · Paper page
  40. McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288–4297 (2012). · DOI · Paper page
  41. Martin, L. et al. Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutations. Cancer Res. 74, 3104–3113 (2014). · DOI
  42. Dvinge, H. et al. Sample processing obscures cancer-specific alterations in leukemic transcriptomes. Proc. Natl Acad. Sci. USA 111, 16802–16807 (2014). · DOI
  43. Katz, Y., Wang, E. T., Airoldi, E. M. & Burge, C. B. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat. Methods 7, 1009–1015 (2010). · DOI · Paper page
  44. Flicek, P. et al. Ensembl 2013. Nucleic Acids Res. 41, D48–D55 (2013). · DOI
  45. Meyer, L. R. et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res. 41, D64–D69 (2013). · DOI
  46. Sheth, N. et al. Comprehensive splice-site analysis using comparative genomics. Nucleic Acids Res. 34, 3955–3967 (2006). · DOI
  47. Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011). · DOI · Paper page
  48. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009). · DOI · Paper page
  49. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-seq. Bioinformatics 25, 1105–1111 (2009). · DOI
  50. Wagenmakers, E. J., Lodewyckx, T., Kuriyal, H. & Grasman, R. Bayesian hypothesis testing for psychologists: a tutorial on the Savage–Dickey method. Cogn. Psychol. 60, 158–189 (2010). · DOI · Paper page
  51. Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2016). · DOI
  52. Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996–1006 (2002). · DOI · Paper page
  53. Wagih, O. ggseqlogo: a versatile R package for drawing sequence logos. Bioinformatics 33, 3645–3647 (2017). · DOI
  54. Huber, W. et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat. Methods 12, 115–121 (2015). · DOI

Cited by

See all 108

Metadata

Authors
Inoue, D., Polaski, J. T., Taylor, J., Castel, P., Chen, S., Kobayashi, S., Hogg, S. J., Hayashi, Y., Pineda, J. M. B., El Marabti, E., Erickson, C., Knorr, K., Fukumoto, M., Yamazaki, H., Tanaka, A., Fukui, C., Lu, S. X., Durham, B. H., Liu, B., Wang, E., Mehta, S., Zakheim, D., Garippa, R., Penson, A., Chew, G.-L., McCormick, F., Bradley, R. K., & Abdel-Wahab, O.
Venue
Nature Genetics
Publisher
Springer Science and Business Media LLC
Published
2021-04-12
Volume
53
Issue
5
Pages
707-718
ISSN
  • 1061-4036
  • 1546-1718
DOI
10.1038/s41588-021-00828-9
PMC
PMC8177065
Cited by
108
References
8
Language
en
Licence
Funders
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL128239, R01 HL151651)
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA251138, 1K08CA230319-01, T32 CA009657)
  • U.S. Department of Defense (W81XWH-12-1-0041)
  • Japan Agency for Medical Research and Development (JP19cm0106165, JP20cm0106165)
  • MEXT | Japan Society for the Promotion of Science (JP20H00537, JP 20H03717)
  • U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK103854)
  • Leukemia and Lymphoma Society (8023-20)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review